🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the makers of acetaminophen, asserting the corporations concealed alleged dangers that the drug presented to children's neurological development.

The lawsuit follows four weeks after Donald Trump publicized an unsubstantiated connection between taking acetaminophen - also known as paracetamol - while pregnant and autism in young ones.

Paxton is taking legal action against Johnson & Johnson, which previously sold the medication, the exclusive pain medication suggested for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a statement, he claimed they "misled consumers by gaining financially from discomfort and marketing drugs ignoring the potential hazards."

The manufacturer asserts there is insufficient reliable data tying acetaminophen to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering countless individuals to boost earnings," Paxton, a Republican, stated.

Kenvue said in a statement that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its online platform, the company also mentioned it had "consistently assessed the relevant science and there is lacking reliable evidence that demonstrates a verified association between consuming acetaminophen and autism."

Organizations speaking for physicians and health professionals concur.

ACOG has declared paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to manage discomfort and fever, which can present significant medical dangers if not addressed.

"In more than two decades of investigation on the utilization of acetaminophen in pregnancy, zero credible investigations has successfully concluded that the usage of paracetamol in any stage of pregnancy causes brain development issues in offspring," the association commented.

The court filing mentions recent announcements from the Trump administration in claiming the drug is potentially dangerous.

In recent weeks, the former president raised alarms from medical authorities when he instructed expectant mothers to "struggle intensely" not to take Tylenol when sick.

Federal regulators then published an announcement that physicians should think about restricting the use of acetaminophen, while also mentioning that "a proven link" between the medication and autism spectrum disorder in children has not been established.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had vowed in April to conduct "extensive scientific investigation" that would determine the source of autism spectrum disorder in a short period.

But authorities advised that identifying a unique factor of autism - considered by experts to be the consequence of a intricate combination of genetic and external influences - would be difficult.

Autism is a category of enduring cognitive variation and disability that affects how persons perceive and interact with the environment, and is recognized using medical professional evaluations.

In his legal document, the attorney general - a Trump ally who is seeking the Senate - alleges Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the science" around paracetamol and autism spectrum disorder.

The lawsuit aims to force the companies "remove any marketing or advertising" that claims acetaminophen is reliable for expectant mothers.

The Texas lawsuit echoes the grievances of a assembly of parents of children with autism and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in two years ago.

The court dismissed the legal action, stating research from the plaintiffs' authorities was inconclusive.